Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Outcomes of Frailty Subgroups Treated with Teclistamab in the Real-World: An International Myeloma Foundation Study Database Analysis

Hira Mian, Carlyn Rose Tan, Sireesha Asoori, Rakesh Popat, Nadine Abdallah, Saurabh Chhabra, Ricardo D. Parrondo, Gregory R Pond, Thomas Martin, Brian G.M. Durie, Yi Lin

Blood (2024) 144 (Supplement 1): 704.

https://doi.org/10.1182/blood-2024-200877

Published: 2024

Journal Articles

Trajectories of Frailty Categorization over Time Among Real-World Patients with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Imran Haider, Darryl P. Leong, Martha L Louzada, Arleigh McCurdy, Gregory R Pond, Ruthanne Cameron, Mohammed Aljama, Alissa Visram, Tanya M. Wildes, Hira Mian

Blood (2024) 144 (Supplement 1): 703.

https://doi.org/10.1182/blood-2024-205524

Published: 2024

Journal Articles

Longitudinal Changes in Cognition in Older Individuals Receiving Lymphoma-Directed Therapy: A Pilot Feasibility Study

Amaris K Balitsky, Gregory R Pond, Hira Mian, Gwynivere A Davies, Ronan Foley, Graeme Andrew McCrae Fraser, Jonathan Sussman, C. Tom Kouroukis

Blood (2024) 144 (Supplement 1): 3753.

https://doi.org/10.1182/blood-2024-200461

Published: 2024

Journal Articles

Subsequent Primary Malignancies in Patients with Indolent B Cell Non-Hodgkin Lymphoma Receiving Frontline Bendamustine Rituximab Therapy

Gwynivere A Davies, Anca Prica, Zharmaine Ante, Ning Liu, Gregory R Pond, Amaris K Balitsky, Lee Mozessohn

Blood (2024) 144 (Supplement 1): 3749.

https://doi.org/10.1182/blood-2024-211926

Published: 2024

Journal Articles

Secondary Cancers Among Patients with Multiple Myeloma: A 15-Year Analysis of a Population-Based Cohort in Ontario, Canada

Alissa Visram, Rajshekhar Chakraborty, Gregory R Pond, Hsien Seow, Anastasia Gayowsky, Ghulam Rehman Mohyuddin, Samer Al Hadidi, Alejandro Garcia-Horton, Rafael Fonseca, Hira Mian

Blood (2024) 144 (Supplement 1): 5170.3.

https://doi.org/10.1182/blood-2024-200956

Published: 2024

Journal Articles

Patient Characteristics and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Patients - a Multicenter Canadian Study

Alexander Ruzic, Emily Trus, Gregory R Pond, Ram Vasudevan Nampoothiri, Vinita Dhir, Andrew Poskus, Louise Bordeleau, Michael Trus

Blood (2024) 144 (Supplement 1): 4878.

https://doi.org/10.1182/blood-2024-200297

Published: 2024

Journal Articles

Variable Frailty Categorization Among Real-World Patient with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Hira S Mian, Martha L Louzada, Arleigh McCurdy, Ruthanne Cameron, Gregory R Pond, Tanya Wildes, Darryl Leong

Blood (2022) 140 (Supplement 1): 2395–2396.

https://doi.org/10.1182/blood-2022-158301

Published: 2022

Journal Articles

Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphomas

Amaris K. Balitsky, Gregory R Pond, Graeme Fraser, Tom Kouroukis, Stephen Ronan Foley

Blood (2022) 140 (Supplement 1): 8036–8037.

https://doi.org/10.1182/blood-2022-165674

Published: 2022

Journal Articles

Causes of Death Among Patients with Multiple Myeloma: A 10 Year Longitudinal Analysis of a Population-Based Cohort in Ontario, Canada

Arleigh McCurdy, Hsien Seow, Gregory R Pond, Anastasia Gayowsky, Rajshekhar Chakraborty, Alissa Visram, Rayan Kaedbey, Anita D'Souza, Ghulam Rehman Mohyuddin, Rafael Fonseca, Hira S Mian

Blood (2022) 140 (Supplement 1): 427–429.

https://doi.org/10.1182/blood-2022-157815

Published: 2022

Journal Articles

Is Symptom Burden Associated with Health Care Utilization: A Longitudinal Population-Based Cohort Study of Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma

Hira S Mian, Rinku Sutradhar, Gregory R Pond, Branavan Sivapathasundaram, Anita D'Souza, Tanya M. Wildes, Hsien Seow

Blood (2021) 138 (Supplement 1): 116.

https://doi.org/10.1182/blood-2021-146862

Published: 2021

Journal Articles

Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study

Hira S Mian, MD, Gregory R Pond, PhD PStat, Tanya M. Wildes, MD MSCI, Branavan Sivapathasundaram, MSc, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-133869

Published: 2020

Journal Articles

Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes

Hira S Mian, MD, Gregory R Pond, PhD PStat, Branavan Sivapathasundaram, MSc, Tanya M. Wildes, MD MSCI, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-133369

Published: 2020

Journal Articles

Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort

Hira S Mian, MD, C. Tom Kouroukis, MDMSc,FRCPC, Gregory R Pond, PhD PStat, Hsien Seow, PhD, Jonathan Sussman, MD FRCPC, MSc

Blood (2019) 134 (Supplement_1): 268.

https://doi.org/10.1182/blood-2019-121672

Published: 2019

Journal Articles

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Hira S Mian, MD, Gregory R Pond, PhD PStat, Sascha A Tuchman, MD, Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI

Blood (2019) 134 (Supplement_1): 4774.

https://doi.org/10.1182/blood-2019-122261

Published: 2019

Journal Articles

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

Blood (2005) 105 (10): 4043–4050.

https://doi.org/10.1182/blood-2004-08-3168

Published: 2005

NARROW

Outcomes of Frailty Subgroups Treated with Teclistamab in the Real-World: An International Myeloma Foundation Study Database Analysis

Trajectories of Frailty Categorization over Time Among Real-World Patients with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Longitudinal Changes in Cognition in Older Individuals Receiving Lymphoma-Directed Therapy: A Pilot Feasibility Study

Subsequent Primary Malignancies in Patients with Indolent B Cell Non-Hodgkin Lymphoma Receiving Frontline Bendamustine Rituximab Therapy

Secondary Cancers Among Patients with Multiple Myeloma: A 15-Year Analysis of a Population-Based Cohort in Ontario, Canada

Patient Characteristics and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Patients - a Multicenter Canadian Study

Variable Frailty Categorization Among Real-World Patient with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphomas

Causes of Death Among Patients with Multiple Myeloma: A 10 Year Longitudinal Analysis of a Population-Based Cohort in Ontario, Canada

Is Symptom Burden Associated with Health Care Utilization: A Longitudinal Population-Based Cohort Study of Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma

Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study

Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes

Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only